C l i n i c a l m e d i c i n e

HIGHLIGHTS

• who: AstraZeneca and collaborators from the DepartmentUniversity of ville, Pennsylvania, USA have published the paper: C L I N I C A L M E D I C I N E, in the Journal: (JOURNAL) of February/17,/2016
• what: This study shows a biphasic B cell response, where peripheral B cells initially rapidly increased within 1 week of belimumab administration, followed by a decrease within 8 weeks of continuous BLyS neutralization. The study is the first to the knowledge to demonstrate belimumab-induced increases in peripheral memory B cells as early as week 1 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.